Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:33 AM
Ignite Modification Date:
2025-12-25 @ 12:33 AM
NCT ID:
NCT05763667
Eligibility Criteria:
Inclusion Criteria:
1. Age 18-80
2. Patients undergoing laparoscopic or robotic hysterectomy; may include other procedures (e.g. lymph node removal)
3. Endometrial cancer or endometrial intraepithelial neoplasia
4. Able to consent to study
Exclusion Criteria:
1. Known clinically significant allergy to bupivacaine or liposomal bupivacaine
2. ASA IV or V
3. Emergency surgery
4. Current chronic opiate use
5. Current pregnancy or breastfeeding
6. Severe hepatic or renal impairment
7. Hysterectomy is not for endometrial cancer or endometrial intraepithelial neoplasia
Healthy Volunteers:
False
Sex:
FEMALE
Minimum Age:
18 Years
Maximum Age:
80 Years
Study:
NCT05763667
Study Brief:
Protocol Section:
NCT05763667